Body composition helps to elucidate the different origins of low serum magnesium in children with obesity compared to children with type 1 diabetes.


Journal

European journal of pediatrics
ISSN: 1432-1076
Titre abrégé: Eur J Pediatr
Pays: Germany
ID NLM: 7603873

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 13 03 2023
accepted: 29 05 2023
revised: 25 05 2023
medline: 28 8 2023
pubmed: 8 6 2023
entrez: 8 6 2023
Statut: ppublish

Résumé

Hypomagnesemia in patients with type 1 diabetes (T1D) as well as in obesity has been related to insulin resistance in adults, but not yet in pediatric patients. In this observational single-center study, we aimed to investigate the relation between the magnesium homeostasis, insulin resistance, and body composition in children with T1D and in children with obesity. Children with T1D (n = 148) and children with obesity and proven insulin resistance (n = 121) and healthy controls (n = 36) were included in this study. Serum and urine samples were collected to determine magnesium and creatinine. The total daily dose of insulin (for children with T1D), results from the oral glucose tolerance test (OGTT, for children with obesity), and biometric data were extracted from the electronic patient files. Furthermore, body composition was measured via bioimpedance spectroscopy. Serum magnesium levels were decreased in both children with obesity (0.87 ± 0.07 mmol/l) and children with T1D (0.86 ± 0.07 mmol/l) compared to healthy controls (0.91 ± 0.06; p = 0.005). A lower magnesium level was associated with more severe adiposity in children with obesity, while a worse glycemic control was associated with lower magnesium levels in children with T1D.   Conclusion: Children with T1D and children with obesity have decreased serum magnesium levels. An increased fat mass is associated with lower magnesium levels in childhood obesity, indicating that the adipose tissue is an important factor in magnesium homeostasis. In contrast, glycemic control was the main determining factor for serum magnesium levels in children with T1D. What is Known: • Hypomagnesaemia has been related to insulin resistance in both adults with T1D and adults with obesity. • There is an increasing prevalence of obesity and T1D in childhood, but little is known about the relationship between magnesium and insulin resistance in these children. What is New: • Both children with T1D and children with obesity have decreased serum magnesium levels. • In childhood obesity an increased fat mass is associated with lower magnesium levels, while glycaemic control is the main determining factor for serum magnesium in children with T1D.

Identifiants

pubmed: 37289233
doi: 10.1007/s00431-023-05046-5
pii: 10.1007/s00431-023-05046-5
doi:

Substances chimiques

Magnesium I38ZP9992A
Blood Glucose 0

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3743-3753

Subventions

Organisme : Fonds Wetenschappelijk Onderzoek
ID : 150179

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH (2016) Hypomagnesemia in type 2 diabetes: a vicious circle? Diabetes 65(1):3–13. Epub 2015/12/24. https://doi.org/10.2337/db15-1028 . PubMed PMID: 26696633
Ledeganck KJ, Anne C, De Monie A, Meybosch S, Verpooten GA, Vinckx M et al (2018) Longitudinal study of the role of epidermal growth factor on the fractional excretion of magnesium in children: effect of calcineurin inhibitors. Nutrients 10(6). Epub 2018/06/05. https://doi.org/10.3390/nu10060677 . PubMed PMID: 29861470; PubMed Central PMCID: PMCPMC6024309
Jahnen-Dechent W, Ketteler M (2012) Magnesium basics. Clin Kidney J 5(Suppl 1):i3–i14. Epub 2012/02/01. https://doi.org/10.1093/ndtplus/sfr163 . PubMed PMID: 26069819; PubMed Central PMCID: PMCPMC4455825
Olza J, Aranceta-Bartrina J, Gonzalez-Gross M, Ortega RM, Serra-Majem L, Varela-Moreiras G et al (2017) Reported dietary intake, disparity between the reported consumption and the level needed for adequacy and food sources of calcium, phosphorus, magnesium and vitamin D in the Spanish population: findings from the ANIBES study. Nutrients 9(2). Epub 2017/02/24. https://doi.org/10.3390/nu9020168 . PubMed PMID: 28230782; PubMed Central PMCID: PMCPMC5331599
Sales CH, Pedrosa Lde F (2006) Magnesium and diabetes mellitus: their relation. Clin Nutr 25(4):554–62. Epub 2006/05/13. https://doi.org/10.1016/j.clnu.2006.03.003 . PubMed PMID: 16690176
Oost LJ, van Heck JIP, Tack CJ, de Baaij JHF (2022) The association between hypomagnesemia and poor glycaemic control in type 1 diabetes is limited to insulin resistant individuals. Sci Rep 2022;12(1):6433. Epub 2022/04/21. https://doi.org/10.1038/s41598-022-10436-0 . PubMed PMID: 35440685; PubMed Central PMCID: PMCPMC9018833
Shahbah D, Hassan T, Morsy S, Saadany HE, Fathy M, Al-Ghobashy A et al (2017) Oral magnesium supplementation improves glycemic control and lipid profile in children with type 1 diabetes and hypomagnesaemia. Medicine 96(11):e6352. Epub 2017/03/16. https://doi.org/10.1097/MD.0000000000006352 . PubMed PMID: 28296769; PubMed Central PMCID: PMCPMC5369924
Ayuk J, Gittoes NJ (2014) Contemporary view of the clinical relevance of magnesium homeostasis. Ann Clin Biochem 51(Pt 2):179–88. Epub 2014/01/10. https://doi.org/10.1177/0004563213517628 . PubMed PMID: 24402002
Karnik S, Kanekar A (2012) Childhood obesity: a global public health crisis. Int J Prev Med 3(1):1–7. Epub 2012/04/17. PubMed PMID: 22506094; PubMed Central PMCID: PMCPMC3278864
Fleischman A, Rhodes ET (2009) Management of obesity, insulin resistance and type 2 diabetes in children: consensus and controversy. Diabetes Metab Syndr Obes 2:185–202. Epub 2009/01/01. PubMed PMID: 21437133; PubMed Central PMCID: PMCPMC3048003
Gunther T (2010) The biochemical function of Mg(2)+ in insulin secretion, insulin signal transduction and insulin resistance. Magnesium Res 23(1):5–18. Epub 2010/03/17. https://doi.org/10.1684/mrh.2009.0195 . PubMed PMID: 20228013
Piuri G, Zocchi M, Della Porta M, Ficara V, Manoni M, Zuccotti GV et al (2021) Magnesium in obesity, metabolic syndrome, and type 2 diabetes. Nutrients 13(2). Epub 2021/01/28. https://doi.org/10.3390/nu13020320 . PubMed PMID: 33499378; PubMed Central PMCID: PMCPMC7912442
March CA, Becker DJ, Libman IM (2021) Nutrition and obesity in the pathogenesis of youth-onset type 1 diabetes and its complicatiOns. Front Endocrinol (Lausanne) 12:622901. Epub 2021/04/09. https://doi.org/10.3389/fendo.2021.622901 . PubMed PMID: 33828529; PubMed Central PMCID: PMCPMC8021094
Lin CC, Huang YL (2015) Chromium, zinc and magnesium status in type 1 diabetes. Curr Opin Clin Nutr Metab Care 18(6):588–92. Epub 2015/09/26. https://doi.org/10.1097/MCO.0000000000000225 . PubMed PMID: 26406393
Cleland SJ, Fisher BM, Colhoun HM, Sattar N, Petrie JR (2013) Insulin resistance in type 1 diabetes: what is ‘double diabetes’ and what are the risks? Diabetologia 56(7):1462–70. Epub 2013/04/25. https://doi.org/10.1007/s00125-013-2904-2 . PubMed PMID: 23613085; PubMed Central PMCID: PMCPMC3671104
Vermeiren E, Naets T, Van Eyck A, Vervoort L, Ysebaert M, Baeck N et al (2021) Improving treatment outcome in children with obesity by an online self-control training: a randomized controlled trial. Front Pedia 9:794256. Epub 2022/01/11. https://doi.org/10.3389/fped.2021.794256 . PubMed PMID: 35004547; PubMed Central PMCID: PMCPMC8733681
Eyzaguirre F, Mericq V. Insulin resistance markers in children. Horm Res. 2009;71(2):65–74. Epub 2009/01/09. https://doi.org/10.1159/000183894 . PubMed PMID: 19129710.
Ten S, Maclaren N (2004) Insulin resistance syndrome in children. J Clin Endocrinol Metabol 89(6):2526–39. Epub 2004/06/08. https://doi.org/10.1210/jc.2004-0276 . PubMed PMID: 15181020
Roelants M, Hauspie R, Hoppenbrouwers K (2009) References for growth and pubertal development from birth to 21 years in Flanders, Belgium. Ann Hum Biol 36(6):680–94. Epub 2009/11/19. https://doi.org/10.3109/03014460903049074 . PubMed PMID: 19919503
Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320(7244):1240–3. Epub 2000/05/08. https://doi.org/10.1136/bmj.320.7244.1240 . PubMed PMID: 10797032; PubMed Central PMCID: PMCPMC27365
Van Eyck A, Eerens S, Trouet D, Lauwers E, Wouters K, De Winter BY et al (2021) Body composition monitoring in children and adolescents: reproducibility and reference values. Eur J Pedia 180(6):1721–32. Epub 2021/01/23. https://doi.org/10.1007/s00431-021-03936-0 . PubMed PMID: 33481106; PubMed Central PMCID: PMCPMC8105252
Cochat P (2002) ESPN handbook: European society for paediatric nephrology; Medcom; Lyon, France.
Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA et al (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20(3):629–37. Epub 2009/01/23. https://doi.org/10.1681/ASN.2008030287 . PubMed PMID: 19158356; PubMed Central PMCID: PMCPMC2653687
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419 PubMed PMID: 3899825
doi: 10.1007/BF00280883 pubmed: 3899825
Flynn JT, Falkner BE (2017) New clinical practice guideline for the management of high blood pressure in children and adolescents. Hypertension 70(4):683–686. https://doi.org/10.1161/HYPERTENSIONAHA.117.10050 . PubMed PMID: 28827475
doi: 10.1161/HYPERTENSIONAHA.117.10050 pubmed: 28827475
Celik N, Andiran N, Yilmaz AE (2011) The relationship between serum magnesium levels with childhood obesity and insulin resistance: a review of the literature. J Pediatr Endocrinol Metab 24(9–10):675–678. Epub 2011/12/08 PubMed PMID: 22145455
Hassan SAU, Ahmed I, Nasrullah A, Haq S, Ghazanfar H, Sheikh AB et al (2017) Comparison of Serum magnesium levels in overweight and obese children and normal weight children. Cureus 9(8):e1607. https://doi.org/10.7759/cureus.1607 . PubMed PMID: 29075585; PubMed Central PMCID: PMC5654973
Huerta MG, Roemmich JN, Kington ML, Bovbjerg VE, Weltman AL, Holmes VF et al (2005) Magnesium deficiency is associated with insulin resistance in obese children. Diabet Care 28(5):1175–81. Epub 2005/04/28. https://doi.org/10.2337/diacare.28.5.1175 . PubMed PMID: 15855585
Schuchardt JP, Hahn A (2017) Intestinal absorption and factors influencing bioavailability of magnesium-an update. Curr Nutr Food Sci 13(4):260–78. Epub 2017/11/11. https://doi.org/10.2174/1573401313666170427162740 . PubMed PMID: 29123461; PubMed Central PMCID: PMCPMC5652077
Lu L, Chen C, Yang K, Zhu J, Xun P, Shikany JM et al (2020) Magnesium intake is inversely associated with risk of obesity in a 30-year prospective follow-up study among American young adults. Eur J Nutr 59(8):3745–53. Epub 2020/02/26. https://doi.org/10.1007/s00394-020-02206-3 . PubMed PMID: 32095867; PubMed Central PMCID: PMCPMC7483156
Devaux S, Adrian M, Laurant P, Berthelot A, Quignard-Boulange A (2016) Dietary magnesium intake alters age-related changes in rat adipose tissue cellularity. Magnes Res 29(4):175–83. Epub 2017/01/31. https://doi.org/10.1684/mrh.2016.0406 . PubMed PMID: 28132954
Cruz KJ, de Oliveira AR, Pinto DP, Morais JB, Lima Fda S, Colli C et al (2014) Influence of magnesium on insulin resistance in obese women. Biol Trace Elem Res 160(3):305–10. Epub 2014/07/06. https://doi.org/10.1007/s12011-014-0044-2 . PubMed PMID: 24984789
Morais JB, Severo JS, Santos LR, de Sousa Melo SR, de Oliveira Santos R, de Oliveira AR et al (2017) Role of magnesium in oxidative stress in individuals with obesity. Biol Trace Elem Res 176(1):20–6. Epub 2016/07/23. https://doi.org/10.1007/s12011-016-0793-1 . PubMed PMID: 27444303
Stevens LA, Padala S, Levey AS (2010) Advances in glomerular filtration rate-estimating equations. Curr Opin Nephrol Hypertens 19(3):298–307. Epub 2010/04/16. https://doi.org/10.1097/MNH.0b013e32833893e2 . PubMed PMID: 20393287; PubMed Central PMCID: PMCPMC3192437
Koch VH (2021) Obesity facts and their influence on renal function across the life span. Front Med (Lausanne) 8:704409. Epub 2021/12/07. https://doi.org/10.3389/fmed.2021.704409 . PubMed PMID: 34869407; PubMed Central PMCID: PMCPMC8632716.
Wuerzner G, Bochud M, Giusti V, Burnier M (2011) Measurement of glomerular filtration rate in obese patients: pitfalls and potential consequences on drug therapy. Obes Facts 4(3):238–43. Epub 2011/06/28. https://doi.org/10.1159/000329547 . PubMed PMID: 21701241; PubMed Central PMCID: PMCPMC6444551
Galli-Tsinopoulou A, Maggana I, Kyrgios I, Mouzaki K, Grammatikopoulou MG, Stylianou C et al (2014) Association between magnesium concentration and HbA1c in children and adolescents with type 1 diabetes mellitus. J Diabetes 6(4):369–77. Epub 2014/01/08. https://doi.org/10.1111/1753-0407.12118 . PubMed PMID: 24393429
Lin CC, Tsweng GJ, Lee CF, Chen BH, Huang YL (2016) Magnesium, zinc, and chromium levels in children, adolescents, and young adults with type 1 diabetes. Clin Nut 35(4):880–4. Epub 2015/06/23. https://doi.org/10.1016/j.clnu.2015.05.022 . PubMed PMID: 26096861
Shahbah D, El Naga AA, Hassan T, Zakaria M, Beshir M, Al Morshedy S et al (2016) Status of serum magnesium in Egyptian children with type 1 diabetes and its correlation to glycemic control and lipid profile. Medicine 95(47):e5166. Epub 2016/11/29. https://doi.org/10.1097/MD.0000000000005166 . PubMed PMID: 27893657; PubMed Central PMCID: PMCPMC5134850
Wegner M, Araszkiewicz A, Zozulinska-Ziolkiewicz D, Wierusz-Wysocka B, Piorunska-Mikolajczak A, Piorunska-Stolzmann M (2010) The relationship between concentrations of magnesium and oxidized low density lipoprotein and the activity of platelet activating factor acetylhydrolase in the serum of patients with type 1 diabetes. Magnesium Res 23(2):97–104. Epub 2010/05/29. https://doi.org/10.1684/mrh.2010.0207 . PubMed PMID: 20507838
Rodrigues AK, Melo AE, Domingueti CP (2020) Association between reduced serum levels of magnesium and the presence of poor glycemic control and complications in type 1 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab Syndr 14(2):127–34. Epub 2020/02/24. https://doi.org/10.1016/j.dsx.2020.01.015 . PubMed PMID: 32088645
Kieboom B, Ligthart S, Dehghan A, Kurstjens S, de Baaij J, Franco O et al (2017) Serum magnesium and the risk of prediabetes: a population-based cohort study. Diabetologia 60(5):843–853. Epub 2017/02/23. https://doi.org/10.1007/s00125-017-4224-4 . PubMed PMID: 28224192
Donga E, Dekkers OM, Corssmit EP, Romijn JA (2015) Insulin resistance in patients with type 1 diabetes assessed by glucose clamp studies: systematic review and meta-analysis. Eur J Endocrinol 173(1):101–9. Epub 2015/04/23. https://doi.org/10.1530/EJE-14-0911 . PubMed PMID: 25899581
Reinehr T, Holl RW, Roth CL, Wiesel T, Stachow R, Wabitsch M et al (2005) Insulin resistance in children and adolescents with type 1 diabetes mellitus: relation to obesity. Pediatr Diabetes 6(1):5–12. Epub 2005/03/25. https://doi.org/10.1111/j.1399-543X.2005.00093.x . PubMed PMID: 15787895
Ewald U, Gebre-Medhin M, Tuvemo T (1983) Hypomagnesemia in diabetic children. Acta Paediatr Scand 72(3):367–371. Epub 1983/05/01. PubMed PMID: 6880723
doi: 10.1111/j.1651-2227.1983.tb09730.x pubmed: 6880723
Abd El Dayem SM, El-Shehaby AM, Abd El Gafar A, Fawzy A, Salama H (2011) Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients. Scand J Clin Lab Invest 71(5):387–93. Epub 2011/04/12. https://doi.org/10.3109/00365513.2011.573574 . PubMed PMID: 21476826
El Malahi A, Van Elsen M, Charleer S, Dirinck E, Ledeganck K, Keymeulen B et al (2022) Relationship between time in range, glycemic variability, HbA1c, and complications in adults with Type 1 diabetes mellitus. J Clin Endocrinol Metabol 107(2):e570-e81. Epub 2021/09/18. https://doi.org/10.1210/clinem/dgab688 . PubMed PMID: 34534297
Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabet Care 42(8):1593–603. Epub 2019/06/10. https://doi.org/10.2337/dci19-0028 . PubMed PMID: 31177185; PubMed Central PMCID: PMCPMC6973648

Auteurs

Annelies Van Eyck (A)

Laboratory of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium. annelies.vaneyck@uantwerpen.be.
Department of Pediatrics, Antwerp University Hospital, Edegem, Belgium. annelies.vaneyck@uantwerpen.be.

Kristien J Ledeganck (KJ)

Laboratory of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.

Eline Vermeiren (E)

Laboratory of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.

Astrid De Lamper (A)

Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Marie Eysackers (M)

Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Julie Mortier (J)

Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Marinus P Van Vliet (MP)

Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Petrus Broere (P)

Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Melvin Roebersen (M)

Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.

Annick France (A)

Department of Pediatric Endocrinology, Antwerp University Hospital, Edegem, Belgium.

Hilde Dotremont (H)

Laboratory of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Department of Pediatric Endocrinology, Antwerp University Hospital, Edegem, Belgium.

Kim Van Hoorenbeeck (K)

Laboratory of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Department of Pediatrics, Antwerp University Hospital, Edegem, Belgium.

Stijn L Verhulst (SL)

Laboratory of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Department of Pediatrics, Antwerp University Hospital, Edegem, Belgium.

Marieke den Brinker (M)

Laboratory of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Department of Pediatric Endocrinology, Antwerp University Hospital, Edegem, Belgium.

Dominique Trouet (D)

Laboratory of Experimental Medicine and Pediatrics and Member of the Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.
Department of Pediatric Nephrology, Antwerp University Hospital, Edegem, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH